(ADMA) ADMA Biologics - Performance 214.1% in 12m
Compare ADMA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
78.45%
#5 in Group
Rel. Strength
98.90%
#85 in Universe
Total Return 12m
214.13%
#4 in Group
Total Return 5y
536.16%
#3 in Group
P/E 25.0
64th Percentile in Group
P/E Forward 29.0
77th Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield 2.31%
93th Percentile in Group
12m Total Return: ADMA (214.1%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ADMA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ADMA
| Total Return (including Dividends) | ADMA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 27.80% | -5.85% | -3.01% |
| 3 Months | 12.58% | -11.95% | -3.15% |
| 12 Months | 214.13% | -11.00% | 10.19% |
| 5 Years | 536.16% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | ADMA | XBI | S&P 500 |
| 1 Month | 80.8% | -59.8% | -5.5% |
| 3 Months | 39.3% | -70.5% | -58.4% |
| 12 Months | 70.4% | -6.9% | 84.1% |
| 5 Years | 79.5% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #14 | 35.7% | 31.8% |
| 3 Month | #26 | 27.9% | 16.2% |
| 12 Month | #4 | 253% | 185% |
| 5 Years | #4 | 532% | 178% |
FAQs
Does ADMA ADMA Biologics outperforms the market?
Yes,
over the last 12 months ADMA made 214.13%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ADMA made 12.58%, while XBI made -11.95%.
Over the last 3 months ADMA made 12.58%, while XBI made -11.95%.
Performance Comparison ADMA vs Indeces and Sectors
ADMA vs. Indices ADMA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.41% | 30.8% | 3.87% | 204% |
| US NASDAQ 100 | QQQ | 4.39% | 31.9% | 4.64% | 206% |
| US Dow Jones Industrial 30 | DIA | 3.21% | 29.9% | 2.95% | 205% |
| German DAX 40 | DAX | 4.71% | 31.2% | -12.9% | 192% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.70% | 27.6% | 19.1% | 205% |
| Hongkong Hang Seng | HSI | 1.44% | 25.0% | 13.1% | 197% |
| India NIFTY 50 | INDA | 2.38% | 19.9% | 14.2% | 213% |
| Brasil Bovespa | EWZ | 3.30% | 19.5% | 11.9% | 226% |
ADMA vs. Sectors ADMA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.95% | 31.6% | -4.24% | 195% |
| Consumer Discretionary | XLY | 2.65% | 31.6% | 0.51% | 200% |
| Consumer Staples | XLP | 0.62% | 29.6% | 3.03% | 203% |
| Energy | XLE | 2.32% | 19.8% | -1.71% | 213% |
| Financial | XLF | 2.93% | 30.5% | -8.29% | 192% |
| Health Care | XLV | 2.99% | 31.0% | 8.57% | 212% |
| Industrial | XLI | 3.10% | 28.5% | 4.58% | 206% |
| Materials | XLB | 2.31% | 27.3% | 12.0% | 218% |
| Real Estate | XLRE | 1.37% | 30.5% | 6.99% | 201% |
| Technology | XLK | 4.54% | 31.8% | 8.99% | 212% |
| Utilities | XLU | 0.12% | 27.0% | 4.75% | 189% |
| Aerospace & Defense | XAR | 4.01% | 26.5% | -0.05% | 193% |
| Biotech | XBI | 7.97% | 33.7% | 21.6% | 225% |
| Homebuilder | XHB | 2.91% | 27.7% | 23.3% | 222% |
| Retail | XRT | 1.11% | 28.3% | 7.95% | 219% |